Skip to main content
Download PDF

Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming

Journal of Hematology & Oncology volume 13, Article number: 44 (2020) Cite this article

The Original Article was published on 07 February 2020

Correction to: Journal of Hematology & Oncology (2020) 13:12

https://doi.org/10.1186/s13045-019-0841-3

The original article [1] contains an error in Fig. 3c and Fig. 3g whereby the image of group WT and NC in HCCLM3 cell lines were repeated. The correct presentations of Fig. 3c and Fig. 3g can be seen ahead.

Fig. 3
figure 1

MiR-612 suppresses invasion and migration of HCC by targeting hadha. a, b Cell migration abilities and statistic results of HepG2miR-612-KD and HCCLM3miR-612-OE cells. Scale bars, 200 μm. c, d Cell invasion abilities and statistic results of HepG2miR-612-KD and HCCLM3miR-612-OE cells. Scale bars, 200 μm. e, f Cell migration abilities and statistic results of HepG2hadha-OE and HCCLM3hadha-KD cells. Scale bars, 200 μm. g, h Cell invasion abilities and statistic results of HepG2hadha-OE and HCCLM3hadha-KD cells. Cell migration abilities and statistic results of HepG2miR-612-KD cells after hadha was knocked down. Scale bars, 200 μm. i, j Cell migration abilities and statistic results of HCCLM3 miR-612-OE cells after HADHA was rescued. Scale bars, 50 μm. k, l Cells (*p < 0.05; **p < 0.01). Data are mean ± SEM of three independent experiments. Scale bars, 50 μm

Full size image

Reference

  1. Liu Y, et al. MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming. J Hematol Oncol. 2020;13:12 https://doi.org/10.1186/s13045-019-0841-3.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Yang Liu, Li-Li Lu and Duo Wen contributed equally to this work.

Authors and Affiliations

  1. Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, 180 Fenglin Road, Shanghai, 200032, China

    Yang Liu, Li-Li Lu, Duo Wen, Dong-Li Liu, Li-Li Dong, Dong-Mei Gao, Xin-Yu Bian, Jian Zhou, Jia Fan & Wei-Zhong Wu

  2. Department of Oral Maxillofacial-Head and Neck Oncology, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

    Yang Liu

  3. Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China

    Duo Wen

  4. Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, 200080, China

    Dong-Li Liu

  5. Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China

    Jian Zhou & Jia Fan

Authors
  1. Yang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li-Li Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Duo Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dong-Li Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Li-Li Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dong-Mei Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xin-Yu Bian
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jian Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jia Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Wei-Zhong Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jia Fan or Wei-Zhong Wu.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Lu, LL., Wen, D. et al. Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming. J Hematol Oncol 13, 44 (2020). https://doi.org/10.1186/s13045-020-00875-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13045-020-00875-5

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us